Demographics and Clinical Characteristics of Patients With Opioid Use Disorder and Offered Medication-Assisted Treatment in the Emergency Department

被引:0
|
作者
Fu, Wayne [1 ,2 ]
Adzhiashvili, Victoria [3 ]
Majlesi, Nima [4 ]
机构
[1] Mercy Hosp, Emergency Med, Buffalo, NY 14220 USA
[2] Staten Isl Univ Hosp, Emergency Med, Staten Isl, NY 10305 USA
[3] Staten Isl Univ Hosp, Psychiat, Staten Isl, NY USA
[4] Staten Isl Univ Hosp, Med Toxicol, Staten Isl, NY USA
关键词
buprenorphine; substance abuse; drug addiction; medication for opioid use disorder; opioid use disorders; BUPRENORPHINE;
D O I
10.7759/cureus.41464
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective The opioid use disorder (OUD) epidemic is a persistent public health crisis in the United States. Medication -assisted treatment (MAT) with opioid agonists, including buprenorphine, is an effective treatment and is commonly initiated in the emergency department (ED). This study describes the demographics and clinical characteristics of OUD patients presenting to the ED and evaluated for MAT. Methodology A retrospective, single-center descriptive study of 129 adult patients presenting to the ED between July 2018 and July 2020 with OUD and evaluated for MAT. Results A total of 129 patients were assessed for MAT. About half (53%) received MAT; the remaining received only a referral (35%) or declined any intervention (12%). The median age was 36 years interquartile range (IQR, 28-46 years) and predominantly male (73%), single (65%), white (73%), unemployed (57%) with public insurance (55%), and without a primary care physician (58%). Majority of the patients presented with opioid withdrawal (62%) or intoxication (15%), while 23% presented with other complaints. About half of the patients (51%) were discharged with a naloxone kit. The majority of the patients were induced with buprenorphine with 4 mg or less (54%) and only 6% of patients received repeat dosing. Conclusions Male, white patients who are unmarried and unemployed, lack primary care follow-up, and rely on public insurance are more likely to be candidates for MAT. Providers should always maintain a high suspicion of opioid misuse and optimize treatment for those in withdrawal. Understanding these characteristics in conjunction with recent health policy changes will hopefully guide and encourage ED-initiated interventions in combating the opioid crisis.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Hyperalgesia in patients on long-term medication-assisted therapy for opioid use disorder
    Tompkins, D.
    Campbell, C.
    Smith, M.
    Edwards, R.
    Strain, E.
    JOURNAL OF PAIN, 2017, 18 (04): : S31 - S31
  • [32] Compliance with Buprenorphine Medication-Assisted Treatment and Relapse to Opioid Use
    Tkacz, Joseph
    Severt, Jamie
    Cacciola, John
    Ruetsch, Charles
    AMERICAN JOURNAL ON ADDICTIONS, 2012, 21 (01): : 55 - 62
  • [33] Opioid Use Disorders, Medication-Assisted Treatment, and the Role of the Laboratory
    Bertholf, Roger L.
    Reisfield, Gary M.
    LABORATORY MEDICINE, 2017, 48 (04) : E57 - E61
  • [34] Being Part of the Solution Initiating Medication-Assisted Treatment in the Emergency Department
    Denno, Jennifer
    Burns, Sheri
    Rucker-Christopher, Zachary
    Suriano, Dominique
    ADVANCED EMERGENCY NURSING JOURNAL, 2022, 44 (02) : 158 - 166
  • [35] Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
    Emma A. van Reekum
    Tea Rosic
    Jacqueline Hudson
    Nitika Sanger
    David C. Marsh
    Andrew Worster
    Lehana Thabane
    Zainab Samaan
    Biology of Sex Differences, 11
  • [36] Shared Medical Appointments as a Tool for the Medication-Assisted Treatment of Opioid Use Disorder: A Review of the Literature
    Wong, Philip
    Santos, Ana
    Guerrero, Andrea
    AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (03): : 274 - 274
  • [37] Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder
    Rosic, Tea
    Worster, Andrew
    Thabane, Lehana
    Marsh, David C.
    Samaan, Zainab
    BJPSYCH OPEN, 2020, 6 (01):
  • [38] Medication-Assisted Treatment for Opioid Use Disorder in Older Adults: An Emerging Role for the Geriatric Psychiatrist
    Joshi, Pallavi
    Shah, Nikita K.
    Kirane, Harshal D.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (04): : 455 - 457
  • [39] Types of Medication-Assisted Treatment for Opioid Use Disorder in Turkey: The Perceptions of Inpatients about Treatment Success
    Erk, Mehmet Aykut
    Firat, Sunay
    PSYCHIATRY INVESTIGATION, 2020, 17 (12) : 1182 - 1190
  • [40] Predictors of Medication-Assisted Treatment Initiation for Opioid Use Disorder in an Interdisciplinary Primary Care Model
    Cantone, Rebecca E.
    Garvey, Brian
    O'Neill, Allison
    Fleishman, Joan
    Cohen, Deborah
    Muench, John
    Bailey, Steffani R.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2019, 32 (05) : 724 - 731